Reported Consolidated quarterly numbers for Max Healthcare Institute Limited are:Net Sales at Rs 1,137.12 crore in September 2022 up 11.67% from Rs. 1,018.33 crore in September 2021.
Quarterly Net Profit at Rs. 457.35 crore in September 2022 up 216.18% from Rs. 144.65 crore in September 2021.
EBITDA stands at Rs. 344.74 crore in September 2022 up 27.51% from Rs. 270.36 crore in September 2021.
Max Healthcare EPS has increased to Rs. 4.72 in September 2022 from Rs. 1.50 in September 2021.
| Max Healthcare shares closed at 456.30 on October 31, 2022 (NSE) and has given 16.57% returns over the last 6 months and 33.11% over the last 12 months. |
| Max Healthcare Institute Limited | | Consolidated Quarterly Results | in Rs. Cr. |
|
| Sep'22 | Jun'22 | Sep'21 | | Net Sales/Income from operations | 1,137.12 | 1,066.27 | 1,018.33 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 1,137.12 | 1,066.27 | 1,018.33 | | EXPENDITURE | | Consumption of Raw Materials | -- | -- | -- | | Purchase of Traded Goods | 227.74 | 219.47 | 219.49 | | Increase/Decrease in Stocks | -1.41 | 0.31 | 33.77 | | Power & Fuel | -- | -- | -- | | Employees Cost | 196.48 | 198.37 | 201.47 | | Depreciation | 57.68 | 57.13 | 53.87 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 395.39 | 383.76 | 324.55 | | P/L Before Other Inc., Int., Excpt. Items & Tax | 261.24 | 207.23 | 185.18 | | Other Income | 25.82 | 31.51 | 31.31 | | P/L Before Int., Excpt. Items & Tax | 287.06 | 238.74 | 216.49 | | Interest | 21.84 | 22.36 | 26.94 | | P/L Before Exceptional Items & Tax | 265.22 | 216.38 | 189.55 | | Exceptional Items | -- | -- | -7.93 | | P/L Before Tax | 265.22 | 216.38 | 181.62 | | Tax | -192.13 | 43.55 | 36.97 | | P/L After Tax from Ordinary Activities | 457.35 | 172.83 | 144.65 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 457.35 | 172.83 | 144.65 | | Minority Interest | -- | -- | -- | | Share Of P/L Of Associates | -- | -- | -- | | Net P/L After M.I & Associates | 457.35 | 172.83 | 144.65 | | Equity Share Capital | 969.68 | 969.63 | 965.95 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 4.72 | 1.78 | 1.50 | | Diluted EPS | 4.71 | 1.78 | 1.49 | | EPS After Extra Ordinary | | Basic EPS | 4.72 | 1.78 | 1.50 | | Diluted EPS | 4.71 | 1.78 | 1.49 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|